Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

1.59
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
1.29
Today|||52-Week Range
4.84
-42.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues7.0M5.2M5.8M6.0M
 
 
 
 
 
Cost of Goods Sold1.9M1.6M1.7M1.5M
 
 
 
 
 
Depreciation And Amortization853.0K835.0K842.0K890.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.3M2.7M3.2M3.6M
 
 
 
 
 
General Expenses9.1M8.2M9.6M8.5M
 
 
 
 
 
Total Operating Expenses11.8M10.7M12.1M10.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.8M-5.5M-6.4M-4.8M
 
 
 
 
 
Extraordinary Charge0.000.00-1.4M-29.0K
 
 
 
Interest Expense On Debt828.0K787.0K1.2M1.8M
 
 
 
 
 
Other Expenses-41.0K-11.0K530.0K80.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-6.3M-8.5M-6.5M
 
 
 
 
 
Income Taxes-73.0K-43.0K-12.0K-74.0K
 
 
 
 
 
Net Income-5.6M-6.3M-8.5M-6.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.9M31.9M32.4M33.8M
 
 
 
 
 
Shares To Calculate EPS Diluted31.9M31.9M32.4M33.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.18-$0.20-$0.26-$0.20
 
 
 
 
 
EPS Diluted-$0.18-$0.20-$0.26-$0.20